This Article Full Text Full Text (PDF) All Versions of this Article: 21/5/1205    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhu, X. Articles by Ezzat, S. Search for Related Content PubMed PubMed Citation Articles by Zhu, X. Articles by Ezzat, S.

Ikaros Is Regulated through Multiple Histone Modifications and Deoxyribonucleic Acid Methylation in the Pituitary

Department of Medicine (X.Z., S.E.), Mount Sinai Hospital and University of Toronto; Department of Pathology (S.L.A.), University Health Network and University of Toronto; and The Ontario Cancer Institute (X.Z., S.L.A., S.E.), Toronto, Ontario, Canada M5G 2M9

Address all correspondence and requests for reprints to: Dr. Shereen Ezzat, Ontario Cancer Institute, 610 University Avenue, 8-327, Toronto, Ontario, Canada M5G 2M9. E-mail: shereen.ezzat{at}utoronto.ca.

The transcription factor Ikaros (Ik) is at the center of a functionally diverse chromatin-remodeling network that is critical for the development and regulation of both the immune and endocrine systems. Dominant negative forms of Ik result in neoplastic growth in mouse genetic studies and have been identified in human tumors. Ik modulates chromatin accessibility through associations with members of the NURD complex including histone deacetylase complexes. We show here that Ik expression in mouse pituitary corticotroph cells is itself regulated through histone modifications as well as DNA methylation. Examination of primary human pituitary specimens also identified a correlation of loss of Ik expression with the presence of DNA methylation in the untranslated exon 1 CpG island. These findings have important implications for the understanding of Ikaros’ role in epigenetic functions and suggest a potential role for demethylating agents in the treatment of related disorders.

This article has been cited by other articles:

				S. Loeper, S. L. Asa, and S. Ezzat Ikaros Modulates Cholesterol Uptake: A Link between Tumor Suppression and Differentiation Cancer Res., May 15, 2008; 68(10): 3715 - 3723. [Abstract] [Full Text] [PDF]